“These providers failed Missouri’s children when they rejected even a diluted medical standard and subjected them to irreversible procedures. My office is not standing for it," says Missouri AG.
Neuralink has received the green light to initiate recruitment for its inaugural human clinical trial, dubbed the PRIME Study (Precise Robotically Implanted Brain-Computer Interface).
